Open AccessPotential Cardiovascular Disease Risk Markers Among HIV-Infected Women Initiating Antiretroviral Treatment
Author(s) -
Robert C. Kaplan,
Alan Landay,
Howard N. Hodis,
Stephen J. Gange,
Philip J. Norris,
Mary Young,
Kathryn Anastos,
Phyllis C. Tien,
Xiaonan Xue,
Jason Lazar,
Christina M. Parrinello,
Lorie Benning,
Russell P. Tracy
Publication year - 2012
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e31825b03be
Subject(s) - medicine , human immunodeficiency virus (hiv) , disease , antiretroviral therapy , antiretroviral treatment , virology , immunology , viral load
Inflammation and hemostasis perturbation may be involved in vascular complications of HIV infection. We examined atherogenic biomarkers and subclinical atherosclerosis in HIV-infected adults before and after beginning highly active antiretroviral therapy (HAART).